Home Neoplasma 2005 Neoplasma Vol.52, p.415-419, 2005

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.52, p.415-419, 2005

Title: Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybridization
Author: J., BEDRNICEK ; A., VICHA ; M., JAROSOVA ; M., HOLZEROVA ; J., CINATL, JR. ; M., MICHAELIS ; J., CINATL ; T., ECKSCHLAGER ;

Abstract: Three parental neuroblastoma cell lines and nine derived lines resistant to Vincristin, Doxorubicin and Cisplatin, respectively, using CGH were studied. CGH profiles of all three parental cell lines were obtained usingDNAfrom a healthy volunteer as reference DNA. Labeled DNAfrom each of the drug resistant daughter cell lines and labeled DNAfrom their parental sensitive cell lines were hybridized to obtain a comparison of gains and losses that accompanied the development of resistance for that particular drug. All three parental cell lines were characterized by typical findings for high risk neuroblastoma: N-myc amplification, gain of 17q, and loss of 1p36.2-36.3. Acquired drug resistance in the neuroblastoma cell lines appeared to be accompanied by a large array of DNA sequence copy number changes. The regions frequently affected in chemoresistant cell lines included gains of 13q14.1-32, and 7q11.2-31.3, 4q. Amplifications were seen at 7q 21.1 consistent with MDR1 amplification in UKF-NB-2 VCR, UKF-NB-3 DOXO, UKF-NB-4 VCR, and UKF-NB-4 DOXO, but not in any Cisplatin resistant line. All Cisplatin and Doxorubicin and two Vincristin resistant line (UKF-NB-2 VCR and UKF-NB-4 VCR) had a deletion of part of 19q or the whole 19 chromosome. All lines resistant to Vincristin or Doxorubicin and two Cisplatin resistant lines (UKF-NB-2 CDDP and UKF-NB-4 CDDP) had a deletion of at least part of 17q, UKF-NB-4 DOXO had deletion of the whole chromosome 17. The loss of 17q may cause chemoresistance by deletion of topoisomerase II? gene. Deletion of 19q in all but one chemoresistant lines may influence of cytochromes P450 genes which are located on 19q13.2. Also gains of 15q22, which were detected in UKF-NB-4 VCR, UKF-NB-2 DOXO and UKF-NB-4 DOXO, may affect other cytochromes P450 genes.

Keywords: neuroblastoma, comparative genomic hybridization, chemoresistance
Year: 2005, Volume: 52, Issue: Page From: 415, Page To: 419

Price: 12.00 €






© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.